Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.31 (
AMP-activated protein kinase
)
13,065
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The energy-sensing kinase
AMP-activated protein kinase
(
AMPK
) is associated with the
sodium-potassium-chloride cotransporter
NKCC2 in the kidney and phosphorylates it on a regulatory site in vitro. To identify a potential role for
AMPK
in salt sensing at the macula densa, we have used the murine macula densa cell line MMDD1. In this cell line,
AMPK
was rapidly activated by isosmolar low-salt conditions. In contrast to the known salt-sensing pathway in the macula densa,
AMPK
activation occurred in the presence of either low sodium or low chloride and was unaffected by inhibition of NKCC2 with bumetanide. Assays using recombinant
AMPK
demonstrated activation of an upstream kinase by isosmolar low salt. The specific calcium/calmodulin-dependent kinase kinase inhibitor STO-609 failed to suppress
AMPK
activation, suggesting that it was not part of the signal pathway.
AMPK
activation was associated with increased phosphorylation of the specific substrate acetyl-CoA carboxylase (ACC) at Ser(79), as well as increased NKCC2 phosphorylation at Ser(126).
AMPK
activation due to low salt concentrations was inhibited by an adenovirus construct encoding a kinase dead mutant of
AMPK
, leading to reduced ACC Ser(79) and NKCC2 Ser(126) phosphorylation. This work demonstrates that
AMPK
activation in macula densa-like cells occurs via isosmolar changes in sodium or chloride concentration, leading to phosphorylation of ACC and NKCC2. Phosphorylation of these substrates in vivo is predicted to increase intracellular chloride and so reduce the effect of salt restriction on tubuloglomerular feedback and renin secretion.
...
PMID:Low salt concentrations activate AMP-activated protein kinase in mouse macula densa cells. 1917 2